 Section 502 (f) of the act provides that a drug shall be deemed to be misbranded : "Unless it labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathological conditions or by children where its use may...  Competitive problems in the drug industry: hearings before Subcommittee on ... - Page 10972by United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly and Anticompetitive Activities, United States. Congress. Senate. Select Committee on Small Business. Subcommittee on Monopoly - 1967 - 15579 pagesFull view - About this book
 | United States - 1935 - 1036 pages
...regulations, as Erovided by sections 701 and 703, against use in such pathological conditions or y children where its use may be dangerous to health,...unsafe dosage or methods or duration of administration of application. The provision is unnecessary in view of the requirement that the labeling contain complete... | |
 | United States. Food and Drug Administration - 1959 - 1068 pages
...usual name of <*•active ingredient; Section 502(f), the labeling of the article failed to bear : adequate directions for use. and (2) such adequate warnings against use in tbo* pathological conditions or by children where its use may be dangerous to hetltl or against unsafe... | |
 | United States. Congress. House. Committee on Interstate and Foreign Commerce - 1946 - 610 pages
...misleading in any particular. * * * (And this is the section Mr. Hoge referred to :) (f) Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathologic conditions or by children where its use may be dangerous to health, or against unsafe dosage... | |
 | United States. Congress. House. Committee on Interstate and Foreign Commerce - 1946 - 606 pages
...shall be deemed to be misbranded— (And this is the section Mr. Hoge referred to:) (f) Unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use in those pathologic conditions or by children where its use may be dangerous to health, or against unsafe dosage... | |
 | United States. Congress. Senate. Committee on Finance - 1948 - 426 pages
...misbranded," and of section 502 (f) of the act which declares a drug "to be misbranded * * * unless its labeling bears (1) adequate directions for use, and (2) such adequate warnings against use * * * dangerous to health, or against unsafe dosage * * * as are necessary for the protection of users."... | |
 | United States. Congress. Senate. Committee on Finance - Margarine - 1948 - 424 pages
...misbranded," and of section 502 (f ) of the act which declares a drug "to be misbranded * * * unless its labeling bears (1) adequate directions for use, and (2) such adequate warnings against use * * * dangerous to health, or against unsafe dosage * * * as are necessary for the protection of users."... | |
 | United States. Congress. Senate. Committee on Finance - Margarine - 1948 - 422 pages
...misbranded," and of section 502 (f ) of the act which declares a drug "to be misbranded * * * unless its labeling bears (1) adequate directions for use, and (2) such adequate warnings against use * * * dangerous to health, or against unsafe dosage * * * as are necessary for the protection of users."... | |
 | United States. Supreme Court - Law reports, digests, etc - 1948 - 968 pages
...part of the labeling of, or the doing of 689 Opinion of the Court. "to be misbranded . . . unless its labeling bears (1) adequate directions for use; and (2) such adequate warnings against use . . . dangerous to health, or against unsafe dosage ... as are necessary for the protection of users."... | |
| |
